Mark Richard Dylewski, MD

Naomi Dempsey, M.D., is a board-certified breast medical oncologist at Miami Cancer Institute, part of Baptist Health. She specializes in breast cancer medical oncology.Prior to joining Miami Cancer Institute in 2023, Dr. Dempsey served as a hematologist and breast medical oncologist at the Lynn Cancer Institute where she led the breast cancer research effort. Her work can be found in various publications, including Breast Cancer Research and Treatment and Hematology Oncology Clinics of North America. Before her time at the Lynn Cancer Institute, Dr. Dempsey was chief fellow of hematology and oncology at University of Miami Sylvester Cancer Center.She is a member of the American Society of Clinical Oncology, Alpha Omega Alpha Medical Honors Society and American College of Physicians.Dr. Dempseys approach to care is compassionate and collaborative. She believes in evidence-based methods tailored to her breast cancer patients goals and priorities for their care. She gets to know the patients and their families to understand what is most important to them in their treatment journey. With this information, she creates a treatment plan that will optimize cancer outcomes while accounting for each patients unique needs and values.When she is not treating patients, Dr. Dempsey enjoys spending time with her daughter Keira. She also plays the flute with the Greater Miami Symphonic Band where she serves as the principal piccolo player.

At Baptist Health Orthopedics in Plantation, has board-certified and fellowship-trained physicians for the treatment of musculoskeletal conditions.

Cesar Ochoa, M.D., is a medical oncologist at Miami Cancer Institute, part of Baptist Health. Dr. Ochoa specializes in the treatment of lung, head and neck cancers. He is fluent in English and Spanish. Prior to joining Miami Cancer Institute in 2021, Dr. Ochoa was on staff at the Billings Clinic Cancer Center, where he worked as a medical oncologist. Throughout his career, Dr. Ochoa has been involved in research focusing on the role of intrinsic and extrinsic airway inflammation in the development and growth of lung cancer. This work has had major implications in the improvement of currently available therapies to better understand lung cancer. Dr. Ochoas research has been published in numerous peer-reviewed publications, including Cancer Research, Cancer Prevention Research, Molecular Cancer, Oncoimmunology, Expert Review of Anticancer Therapy and others. He has also presented his work at multiple national and international conferences. Dr. Ochoa believes that the needs of his patients always come first. He strives to help them understand their disease, prognosis and treatment options while learning about their personal goals and what matters most to them. This way, together, they can develop a management plan that aligns with the patients values.When he is not treating patients, Dr. Ochoa enjoys reading, music, exploring the outdoors and visiting new restaurants.